APA (7th ed.) Citation

Kim, C. E., Kleinman, H. K., Sosne, G., Ousler, G. W., Kim, K., Kang, S., & Yang, J. (2018). RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model. Nature Portfolio.

Chicago Style (17th ed.) Citation

Kim, Chae Eun, Hynda K. Kleinman, Gabriel Sosne, George W. Ousler, Kyeongsoon Kim, Sinwook Kang, and Jaewook Yang. RGN-259 (thymosin β4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugs in a Dry Eye Model. Nature Portfolio, 2018.

MLA (8th ed.) Citation

Kim, Chae Eun, et al. RGN-259 (thymosin β4) Improves Clinically Important Dry Eye Efficacies in Comparison with Prescription Drugs in a Dry Eye Model. Nature Portfolio, 2018.